Circulation Research, Vol 74, 576-585, Copyright © 1994 by American Heart Association

ARTICLES

Expression and insulin-like growth factor-dependent proteolysis of insulin-like growth factor-binding protein-4 are regulated by cell confluence in vascular smooth muscle cells

A Kamyar, CJ Pirola, HM Wang, B Sharifi, S Mohan, JS Forrester and JA Fagin
Division of Cardiology, Cedars-Sinai Medical Center, UCLA School of Medicine 90048.

Insulin-like growth factor (IGF)-I is markedly induced after balloon injury in the rat aorta, where it may serve to mediate vascular repair. Because the bioavailability of IGF-I is modulated by IGF-binding proteins (IGFBPs), we examined the regulation of IGFBPs by IGFs in primary cultures of rat aortic smooth muscle cells (SMCs). Serum- deprived SMC-conditioned medium contains IGFBPs of 38 to 45 kD (only in confluent cultures), 30 kD (possibly IGFBP-2), 28 kD, and 24 kD (IGFBP- 4), the latter being the most abundant. IGF-I and IGF-II but not insulin evoked a marked decrease of IGFBP-4 as early as 4 hours after treatment. IGFBP-4 mRNA abundance, however, was entirely unaffected by IGF-I for up to 48 hours. IGF-I analogues with high affinity for the IGF-I receptor and weak affinity for IGFBP paradoxically evoked a small increase in IGFBP-4, probably through a general increase in protein synthesis. IGF-I only minimally decreased IGFBP-4 content in medium of sparse cultures, whereas it completely abolished IGFBP-4 content in conditioned medium of superconfluent SMCs. IGF-I also evoked a concentration-dependent increase in the abundance of IGFBP-3 in confluent, but not sparse, SMCs without affecting IGFBP-3 mRNA. Addition of IGF-I to cell-free medium conditioned by confluent, but not by sparsely cultured, SMCs led to rapid degradation of IGFBP-4. Interestingly, IGFBP-4 mRNA was markedly induced in confluent relative to sparsely grown SMCs in an IGF-I independent fashion. Thus, both biosynthesis and IGF-dependent proteolysis of IGFBP-4 are increased in confluent SMCs. Proteolysis was maximal at 37 degrees C and was abrogated by EDTA and by benzamidine. Phenylmethylsulfonyl fluoride and the plasmin inhibitor bdellin had minor inhibitory activity, whereas aprotinin, angiotensin-converting enzyme inhibitors, and N- ethylmaleimide were without effect. The protease does not affect the structure of IGF-I as determined by reverse-phase high-performance liquid chromatography and size-exclusion chromatography of 125I-IGF-I incubated for up to 24 hours with SMC-conditioned medium containing IGFBP-4. In summary, SMCs elaborate a cation-dependent protease in a confluence-dependent fashion, which degrades bound IGFBP-4 and likely releases free structurally intact IGF-I, presumably to interact with the cell surface receptor and/or other IGFBPs.

This article has been cited by other articles:

				Z. T. Resch, R. D. Simari, and C. A. Conover Targeted Disruption of the Pregnancy-Associated Plasma Protein-A Gene Is Associated with Diminished Smooth Muscle Cell Response to Insulin-like Growth Factor-I and Resistance to Neointimal Hyperplasia after Vascular Injury Endocrinology, December 1, 2006; 147(12): 5634 - 5640. [Abstract] [Full Text] [PDF]

				P. Delafontaine, Y.-H. Song, and Y. Li Expression, Regulation, and Function of IGF-1, IGF-1R, and IGF-1 Binding Proteins in Blood Vessels Arterioscler Thromb Vasc Biol, March 1, 2004; 24(3): 435 - 444. [Abstract] [Full Text]

				T. Hsieh, R. E. Gordon, D. R. Clemmons, W. H. Busby Jr., and C. Duan Regulation of Vascular Smooth Muscle Cell Responses to Insulin-like Growth Factor (IGF)-I by Local IGF-binding Proteins J. Biol. Chem., October 31, 2003; 278(44): 42886 - 42892. [Abstract] [Full Text] [PDF]

				M. Zhang, E. P. Smith, H. Kuroda, W. Banach, S. D. Chernausek, and J. A. Fagin Targeted Expression of a Protease-resistant IGFBP-4 Mutant in Smooth Muscle of Transgenic Mice Results in IGFBP-4 Stabilization and Smooth Muscle Hypotrophy J. Biol. Chem., June 7, 2002; 277(24): 21285 - 21290. [Abstract] [Full Text] [PDF]

				E. P. Smith, A. Kamyar, W. Niu, J. Wang, B. Cercek, S. D. Chernausek, and J. A. Fagin IGF-Binding Protein-4 Expression and IGF-Binding Protein-4 Protease Activity Are Regulated Coordinately in Smooth Muscle During Postnatal Development and After Vascular Injury Endocrinology, October 1, 2001; 142(10): 4420 - 4427. [Abstract] [Full Text] [PDF]

				J. F. Kuemmerle and B. Teng Regulation of IGFBP-4 levels in human intestinal muscle by an IGF-I-activated, confluence-dependent protease Am J Physiol Gastrointest Liver Physiol, November 1, 2000; 279(5): G975 - G982. [Abstract] [Full Text] [PDF]

				L. Wang and M. L. Adamo Cell Density Influences Insulin-Like Growth Factor I Gene Expression in a Cell Type-Specific Manner Endocrinology, July 1, 2000; 141(7): 2481 - 2489. [Abstract] [Full Text] [PDF]

				J. F. Kuemmerle Endogenous IGF-I regulates IGF binding protein production in human intestinal smooth muscle cells Am J Physiol Gastrointest Liver Physiol, May 1, 2000; 278(5): G710 - G717. [Abstract] [Full Text] [PDF]

				C. Duan, M. B. Liimatta, and O. L. Bottum Insulin-like Growth Factor (IGF)-I Regulates IGF-binding Protein-5 Gene Expression through the Phosphatidylinositol 3-Kinase, Protein Kinase B/Akt, and p70 S6 Kinase Signaling Pathway J. Biol. Chem., December 24, 1999; 274(52): 37147 - 37153. [Abstract] [Full Text] [PDF]

				K. Yano, J. R. Bauchat, M. B. Liimatta, D. R. Clemmons, and C. Duan Down-Regulation of Protein Kinase C Inhibits Insulin-Like Growth Factor I-Induced Vascular Smooth Muscle Cell Proliferation, Migration, and Gene Expression Endocrinology, October 1, 1999; 140(10): 4622 - 4632. [Abstract] [Full Text]

				T. Gustafsson, P. Andersson, Y. Chen, J. O. Magnusson, and H. J. Arnqvist Interaction of angiotensin II and the insulin-like growth factor system in vascular smooth muscle cells Am J Physiol Heart Circ Physiol, August 1, 1999; 277(2): H499 - H507. [Abstract] [Full Text] [PDF]

				R. Rajah, R. V. Nachajon, M. H. Collins, H. Hakonarson, M. M. Grunstein, and P. Cohen Elevated Levels of the IGF-Binding Protein Protease MMP-1 in Asthmatic Airway Smooth Muscle Am. J. Respir. Cell Mol. Biol., February 1, 1999; 20(2): 199 - 208. [Abstract] [Full Text]

				T. L. Bushman and J. F. Kuemmerle IGFBP-3 and IGFBP-5 production by human intestinal muscle: reciprocal regulation by endogenous TGF-beta 1 Am J Physiol Gastrointest Liver Physiol, December 1, 1998; 275(6): G1282 - G1290. [Abstract] [Full Text] [PDF]

				C. Rees, D. R. Clemmons, G. D. Horvitz, J. B. Clarke, and W. H. Busby A Protease-Resistant Form of Insulin-Like Growth Factor (IGF) Binding Protein 4 Inhibits IGF-1 Actions Endocrinology, October 1, 1998; 139(10): 4182 - 4188. [Abstract] [Full Text] [PDF]

				C. Duan and D. R. Clemmons Differential Expression and Biological Effects of Insulin-like Growth Factor-binding Protein-4 and -5 in Vascular Smooth Muscle Cells J. Biol. Chem., July 3, 1998; 273(27): 16836 - 16842. [Abstract] [Full Text] [PDF]

				J. Wang, W. Niu, D. P. Witte, S. D. Chernausek, Y. E. Nikiforov, T. L. Clemens, B. Sharifi, A. R. Strauch, and J. A. Fagin Overexpression of Insulin-Like Growth Factor-Binding Protein-4 (IGFBP-4) in Smooth Muscle Cells of Transgenic Mice through a Smooth Muscle {alpha}-Actin-IGFBP-4 Fusion Gene Induces Smooth Muscle Hypoplasia Endocrinology, May 1, 1998; 139(5): 2605 - 2614. [Abstract] [Full Text] [PDF]

				T. A. Jacot and D. R. Clemmons Effect of Glucose on Insulin-Like Growth Factor Binding Protein-4 Proteolysis Endocrinology, January 1, 1998; 139(1): 44 - 50. [Abstract] [Full Text] [PDF]

				J. L. Fowlkes, K. M. Thrailkill, C. George-Nascimento, C. K. Rosenberg, and D. M. Serra Heparin-Binding, Highly Basic Regions within the Thyroglobulin Type-1 Repeat of Insulin-Like Growth Factor (IGF)-Binding Proteins (IGFBPs) -3, -5, and -6 Inhibit IGFBP-4 Degradation Endocrinology, June 1, 1997; 138(6): 2280 - 2285. [Abstract] [Full Text] [PDF]

				B. Dai, S. G. Widen, R. Mifflin, and P. Singh Cloning of the Functional Promoter for Human Insulin-Like Growth Factor Binding Protein-4 Gene: Endogenous Regulation Endocrinology, January 1, 1997; 138(1): 332 - 343. [Abstract] [Full Text] [PDF]

				J. L. Fowlkes, D. M. Serra, C. K. Rosenberg, and K. M. Thrailkill Insulin-like Growth Factor (IGF)-binding Protein-3 (IGFBP-3) Functions as an IGF-reversible Inhibitor of IGFBP-4 Proteolysis J. Biol. Chem., November 17, 1995; 270(46): 27481 - 27488. [Abstract] [Full Text] [PDF]